Companies
Hvivo to make return to shareholders from strong 2022 results
Pharmaceutical services company expects full-year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year
Pharmaceutical services company expects full-year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year